Drug name - Pexeva
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7598271 | SEBELA IRELAND LTD | Crystalline paroxetine methane sulfonate |
May, 2025
(2 years from now) | |
| CN1092654C | SEBELA IRELAND LTD | 4-Phenyl-Piperidine Compound |
Aug, 2008
(14 years ago) | |
| CN1256692A | SEBELA IRELAND LTD | 4-Phenyl-Piperidine Compound |
Aug, 2008
(14 years ago) | |
| EP994872B1 | SEBELA IRELAND LTD | 4-Phenylpiperidine Compounds |
Jun, 2017
(5 years ago) | |
| EP994872B9 | SEBELA IRELAND LTD | 4-Phenylpiperidine Compounds |
Jun, 2017
(5 years ago) | |
| EP994872A1 | SEBELA IRELAND LTD | 4-Phenylpiperidine Compounds |
Jun, 2017
(5 years ago) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 10MG BASE | TABLET;ORAL | Prescription |
| EQ 20MG BASE | TABLET;ORAL | Prescription |
| EQ 30MG BASE | TABLET;ORAL | Prescription |
| EQ 40MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.